Oxford Nanopore Technologies aims to disrupt the paradigm of biological analysis.  Our technology and commercial model has already opened up DNA analysis to researchers who previously had no direct access to sequencing technologies, freeing them up to perform analyses in their own labs, in real time or in the field.  Over time, the technology will continue to improve, new form factors of the technology will be introduced and workflows will be further simplified by new preparation techniques or analysis workflows. This technology pathway is designed to enable the analysis of any living thing, by any person, in any environment.

Oxford Nanopore has developed the worlds first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology. Commercially available since 2015, the MinION is in use by a thriving community of scientists in >50 countries, where it is enabling myriad applications within the traditional laboratory environment and in the field.

Oxford Nanopore Technologies Executive Team

• Gordon Sanghera, Chief Executive Officer, CBE
• Nick Keher, Chief Financial Officer
• Spike Willcocks, Chief Strategy Officer
• Tim Cowper, Chief Operating Officer
• Zoe McDougall, Global Head, SVP, Corporate Affairs
• Sarah Lapworth, SVP, Global Human Resources
• Jordan Herman, SVP, General Counsel
• Rosemary Sinclair Dokos, Chief Product & Marketing Officer
• Lakmal Jayasinghe, Chief Scientific Officer